Adocia S.A.
OTC: ADOCY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Olivier Soula
- Employees
- 78
- Headquarters
- Lyon, France
- IPO year
- 2014
- Market cap
- $170.4M
- Website
- https://www.adocia.com
Loading ADOCY…
Loading profile data…Frequently asked questions about ADOCY
What does Adocia S.A. (ADOCY) do?
Adocia S.A. is a clinical-stage biotechnology company dedicated to the research and development of novel formulations of established therapeutic proteins and peptides. Its primary focus is on addressing diabetes and various other metabolic disorders. Central to its work is the exclusive BioChaperone technological platform, engineered to signific...
Where does ADOCY trade?
Adocia S.A. (ADOCY) trades on the Other OTC.
What sector is ADOCY in?
Adocia S.A. (ADOCY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Adocia S.A.?
Olivier Soula is the chief executive officer of Adocia S.A. (ADOCY).
Where is Adocia S.A. headquartered?
Adocia S.A. is headquartered in France.
Does ADOCY pay a dividend?
Adocia S.A. (ADOCY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ADOCY go public?
Adocia S.A. (ADOCY) completed its initial public offering in 2014.
Is ADOCY an ADR?
Yes — ADOCY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Adocia S.A. reporting and dividends follow the underlying issuer.